Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

La Jolla, California 92037


Purpose:

The purpose of this study is to demonstrate that patients receiving cangrelor infusion before coronary artery bypass grafting have an acceptable safety profile and can undergo surgery without excessive bleeding peri-operatively.


Criteria:

Inclusion Criteria: - Written informed consent 18 Years of Age non emergent coronary bypass graft surgery Received a thienopyridine within 48 hours prior to enrollment Exclusion Criteria: - Confirmed or suspected pregnancy Cerebrovascular accident within one yar Intracranial neoplasm History of bleeding diathesis Thrombocytopenia


NCT ID:

NCT00767507


Primary Contact:

Principal Investigator
Eric Topol, MD
Scripps


Backup Contact:

N/A


Location Contact:

La Jolla, California 92037
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.